2019
Treating Heart Failure With Antihyperglycemic Medications: Is Now the Right Time?
Testani JM, Inzucchi SE, Voors AA. Treating Heart Failure With Antihyperglycemic Medications: Is Now the Right Time? Circulation 2019, 139: 2383-2385. PMID: 31107618, DOI: 10.1161/circulationaha.119.038854.Commentaries, Editorials and LettersBiomarkersBlood GlucoseDiabetes Mellitus, Type 2Disease ProgressionEvidence-Based MedicineGlucagon-Like Peptide-1 ReceptorHeart FailureHospitalizationHumansIncretinsProtective FactorsRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsSodium-Glucose Transporter 2 InhibitorsTreatment Outcome
2010
Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake via p38&agr; MAP Kinase-Mediated, Nitric Oxide-Dependent Mechanisms in Conscious Dogs With Dilated Cardiomyopathy
Bhashyam S, Fields AV, Patterson B, Testani JM, Chen L, Shen YT, Shannon RP. Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake via p38&agr; MAP Kinase-Mediated, Nitric Oxide-Dependent Mechanisms in Conscious Dogs With Dilated Cardiomyopathy. Circulation Heart Failure 2010, 3: 512-521. PMID: 20466848, PMCID: PMC3075465, DOI: 10.1161/circheartfailure.109.900282.Peer-Reviewed Original ResearchAnalysis of VarianceAnimalsBlood GlucoseCardiomyopathy, DilatedConsciousnessDisease Models, AnimalDogsFemaleGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorGlucose Transporter Type 4HemodynamicsMaleMitochondria, HeartMyocardiumNitric Oxide SynthaseP38 Mitogen-Activated Protein KinasesProbabilityRandom AllocationReceptors, GlucagonSignal TransductionVentricular Function, Left